UniProt ID | DUS3L_HUMAN | |
---|---|---|
UniProt AC | Q96G46 | |
Protein Name | tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like | |
Gene Name | DUS3L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 650 | |
Subcellular Localization | ||
Protein Description | Catalyzes the synthesis of dihydrouridine, a modified base found in the D-loop of most tRNAs.. | |
Protein Sequence | MAEGTAEAPLENGGGGDSGAGALERGVAPIKRQYLTTKEQFHQFLEAKGQEKTCRETEVGDPAGNELAEPEAKRIRLEDGQTADGQTEEAAEPGEQLQTQKRARGQNKGRPHVKPTNYDKNRLCPSLIQESAAKCFFGDRCRFLHDVGRYLETKPADLGPRCVLFETFGRCPYGVTCRFAGAHLRPEGQNLVQEELAARGTQPPSIRNGLDKALQQQLRKREVRFERAEQALRRFSQGPTPAAAVPEGTAAEGAPRQENCGAQQVPAGPGTSTPPSSPVRTCGPLTDEDVVRLRPCEKKRLDIRGKLYLAPLTTCGNLPFRRICKRFGADVTCGEMAVCTNLLQGQMSEWALLKRHQCEDIFGVQLEGAFPDTMTKCAELLSRTVEVDFVDINVGCPIDLVYKKGGGCALMNRSTKFQQIVRGMNQVLDVPLTVKIRTGVQERVNLAHRLLPELRDWGVALVTLHGRSREQRYTKLADWQYIEECVQAASPMPLFGNGDILSFEDANRAMQTGVTGIMIARGALLKPWLFTEIKEQRHWDISSSERLDILRDFTNYGLEHWGSDTQGVEKTRRFLLEWLSFLCRYVPVGLLERLPQRINERPPYYLGRDYLETLMASQKAADWIRISEMLLGPVPPSFAFLPKHKANAYK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEGTAEAP ------CCCCCCCCC | 24.75 | 22814378 | |
31 | Acetylation | ERGVAPIKRQYLTTK HCCCCCCCCCCCCCH | 32.18 | 25953088 | |
34 | Phosphorylation | VAPIKRQYLTTKEQF CCCCCCCCCCCHHHH | 15.28 | 29759185 | |
36 | Phosphorylation | PIKRQYLTTKEQFHQ CCCCCCCCCHHHHHH | 30.78 | 29759185 | |
37 | Phosphorylation | IKRQYLTTKEQFHQF CCCCCCCCHHHHHHH | 29.95 | 29759185 | |
38 | Ubiquitination | KRQYLTTKEQFHQFL CCCCCCCHHHHHHHH | 44.26 | - | |
48 | Acetylation | FHQFLEAKGQEKTCR HHHHHHHCCCCCCCC | 52.32 | 7677919 | |
48 | Ubiquitination | FHQFLEAKGQEKTCR HHHHHHHCCCCCCCC | 52.32 | - | |
73 | Acetylation | ELAEPEAKRIRLEDG CCCCCCCCEEECCCC | 46.85 | 23954790 | |
73 | Ubiquitination | ELAEPEAKRIRLEDG CCCCCCCCEEECCCC | 46.85 | 21906983 | |
73 (in isoform 2) | Ubiquitination | - | 46.85 | 21890473 | |
73 (in isoform 1) | Ubiquitination | - | 46.85 | 21890473 | |
101 | Acetylation | GEQLQTQKRARGQNK CHHHHHHHHHCCCCC | 51.95 | 26051181 | |
101 | Ubiquitination | GEQLQTQKRARGQNK CHHHHHHHHHCCCCC | 51.95 | 21906983 | |
101 (in isoform 1) | Ubiquitination | - | 51.95 | 21890473 | |
101 (in isoform 2) | Ubiquitination | - | 51.95 | 21890473 | |
114 | Ubiquitination | NKGRPHVKPTNYDKN CCCCCCCCCCCCCCC | 42.99 | - | |
120 | Ubiquitination | VKPTNYDKNRLCPSL CCCCCCCCCCCCHHH | 33.34 | - | |
134 | Ubiquitination | LIQESAAKCFFGDRC HHHHHHHHHHHCCHH | 31.15 | - | |
154 (in isoform 2) | Ubiquitination | - | 28.91 | 21890473 | |
154 (in isoform 1) | Ubiquitination | - | 28.91 | 21890473 | |
154 | Ubiquitination | VGRYLETKPADLGPR HHHHHCCCCCCCCCC | 28.91 | 21906983 | |
174 (in isoform 3) | Ubiquitination | - | 8.06 | 21890473 | |
193 (in isoform 3) | Ubiquitination | - | 41.43 | 21890473 | |
212 | Ubiquitination | SIRNGLDKALQQQLR HHHCHHHHHHHHHHH | 56.91 | - | |
212 | Acetylation | SIRNGLDKALQQQLR HHHCHHHHHHHHHHH | 56.91 | 25953088 | |
236 | Phosphorylation | EQALRRFSQGPTPAA HHHHHHHHCCCCCCC | 32.20 | 25159151 | |
240 | Phosphorylation | RRFSQGPTPAAAVPE HHHHCCCCCCCCCCC | 32.17 | 21712546 | |
249 | Phosphorylation | AAAVPEGTAAEGAPR CCCCCCCCCCCCCCC | 22.49 | 20068231 | |
271 | Phosphorylation | QVPAGPGTSTPPSSP CCCCCCCCCCCCCCC | 32.34 | 29255136 | |
272 | Phosphorylation | VPAGPGTSTPPSSPV CCCCCCCCCCCCCCC | 44.85 | 29255136 | |
273 | Phosphorylation | PAGPGTSTPPSSPVR CCCCCCCCCCCCCCC | 38.77 | 29255136 | |
276 | Phosphorylation | PGTSTPPSSPVRTCG CCCCCCCCCCCCCCC | 48.77 | 29255136 | |
277 | Phosphorylation | GTSTPPSSPVRTCGP CCCCCCCCCCCCCCC | 32.94 | 29255136 | |
281 | Phosphorylation | PPSSPVRTCGPLTDE CCCCCCCCCCCCCCH | 23.27 | 30576142 | |
284 (in isoform 3) | Ubiquitination | - | 33.94 | 21890473 | |
286 | Phosphorylation | VRTCGPLTDEDVVRL CCCCCCCCCHHHEEC | 40.24 | 21815630 | |
306 | Ubiquitination | KRLDIRGKLYLAPLT CCCCCCCEEEEECCC | 24.90 | - | |
308 | Phosphorylation | LDIRGKLYLAPLTTC CCCCCEEEEECCCCC | 12.33 | 22817900 | |
354 | Methylation | MSEWALLKRHQCEDI CHHHHHHHHHCCCCC | 49.00 | - | |
377 (in isoform 3) | Ubiquitination | - | 2.33 | 21890473 | |
382 | Phosphorylation | TKCAELLSRTVEVDF HHHHHHHHCCEEEEE | 38.23 | 24719451 | |
403 | Ubiquitination | CPIDLVYKKGGGCAL CCEEEEEECCCCEEE | 37.15 | - | |
404 | Ubiquitination | PIDLVYKKGGGCALM CEEEEEECCCCEEEC | 45.13 | - | |
416 | Ubiquitination | ALMNRSTKFQQIVRG EECCCCHHHHHHHHC | 42.28 | 21890473 | |
416 | Acetylation | ALMNRSTKFQQIVRG EECCCCHHHHHHHHC | 42.28 | 25953088 | |
416 | Sumoylation | ALMNRSTKFQQIVRG EECCCCHHHHHHHHC | 42.28 | 28112733 | |
416 (in isoform 2) | Ubiquitination | - | 42.28 | 21890473 | |
416 (in isoform 1) | Ubiquitination | - | 42.28 | 21890473 | |
435 (in isoform 1) | Ubiquitination | - | 22.64 | 21890473 | |
435 | Ubiquitination | LDVPLTVKIRTGVQE CCCCEEEEECCCHHH | 22.64 | 21890473 | |
435 (in isoform 2) | Ubiquitination | - | 22.64 | 21890473 | |
526 (in isoform 1) | Ubiquitination | - | 34.69 | 21890473 | |
526 | Ubiquitination | IARGALLKPWLFTEI EECCHHHCHHHHHHH | 34.69 | 21890473 | |
534 | Ubiquitination | PWLFTEIKEQRHWDI HHHHHHHHHHCCCCC | 41.38 | - | |
542 | Phosphorylation | EQRHWDISSSERLDI HHCCCCCCHHHHHHH | 25.91 | - | |
543 | Phosphorylation | QRHWDISSSERLDIL HCCCCCCHHHHHHHH | 36.23 | - | |
544 | Phosphorylation | RHWDISSSERLDILR CCCCCCHHHHHHHHH | 21.68 | - | |
580 | Phosphorylation | RFLLEWLSFLCRYVP HHHHHHHHHHHHHCC | 19.76 | 24719451 | |
610 | Phosphorylation | PYYLGRDYLETLMAS CCCCCHHHHHHHHHH | 12.70 | - | |
619 (in isoform 1) | Ubiquitination | - | 42.94 | 21890473 | |
619 | Ubiquitination | ETLMASQKAADWIRI HHHHHHHHHHHHHHH | 42.94 | 2190698 | |
643 | Ubiquitination | PSFAFLPKHKANAYK CHHHCCHHHHCCCCC | 60.94 | - | |
645 | Ubiquitination | FAFLPKHKANAYK-- HHCCHHHHCCCCC-- | 49.84 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DUS3L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DUS3L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DUS3L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
BCAT1_HUMAN | BCAT1 | physical | 22863883 | |
CALU_HUMAN | CALU | physical | 22863883 | |
DPP9_HUMAN | DPP9 | physical | 22863883 | |
U5S1_HUMAN | EFTUD2 | physical | 22863883 | |
T2FA_HUMAN | GTF2F1 | physical | 22863883 | |
KAP1_HUMAN | PRKAR1B | physical | 22863883 | |
RPR1B_HUMAN | RPRD1B | physical | 22863883 | |
SYSC_HUMAN | SARS | physical | 22863883 | |
SC23A_HUMAN | SEC23A | physical | 22863883 | |
GDN_HUMAN | SERPINE2 | physical | 22863883 | |
SNF8_HUMAN | SNF8 | physical | 22863883 | |
XPO5_HUMAN | XPO5 | physical | 22863883 | |
EIF2A_HUMAN | EIF2A | physical | 26344197 | |
TRM6_HUMAN | TRMT6 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-273; SER-276 AND SER-277, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-273; SER-276 AND SER-277, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-273, AND MASSSPECTROMETRY. |